Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Epigenetic Modifications of Nrf2 by 3,3'-diindolylmethane In Vitro in TRAMP C1 Cell Line and In Vivo TRAMP Prostate Tumors.
Wu TY, Khor TO, Su ZY, Saw CL, Shu L, Cheung KL, Huang Y, Yu S, Kong AN.
AAPS J. 2013 May 9. [Epub ahead of print]
Related citations
The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.
Lo R, Matthews J.
Toxicol Appl Pharmacol. 2013 Apr 11;270(2):139-148. doi: 10.1016/j.taap.2013.03.029. [Epub ahead of print]
2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.
Bhowmik A, Das N, Pal U, Mandal M, Bhattacharya S, Sarkar M, Jaisankar P, Maiti NC, Ghosh MK.
PLoS One. 2013;8(3):e59798. doi: 10.1371/journal.pone.0059798. Epub 2013 Mar 28.
3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells.
Ahmad A, Ali S, Ahmed A, Ali AS, Raz A, Sakr WA, Rahman KM.
PLoS One. 2013;8(1):e54657. doi: 10.1371/journal.pone.0054657. Epub 2013 Jan 22.
Indole compounds against breast cancer: recent developments.
Biersack B, Schobert R.
Curr Drug Targets. 2012 Dec;13(14):1705-19.
Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3'-diindolylmethene in human breast epithelial cell lines.
Licznerska BE, Szaefer H, Murias M, Bartoszek A, Baer-Dubowska W.
Eur J Nutr. 2012 Oct 23. [Epub ahead of print]
BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer.
Jiang J, Thyagarajan-Sahu A, Loganathan J, Eliaz I, Terry C, Sandusky GE, Sliva D.
Oncol Rep. 2012 Oct;28(4):1139-45. doi: 10.3892/or.2012.1936. Epub 2012 Jul 26.
Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines.
Szaefer H, Licznerska B, Krajka-Kuźniak V, Bartoszek A, Baer-Dubowska W.
Nutr Cancer. 2012 Aug;64(6):879-88. doi: 10.1080/01635581.2012.690928. Epub 2012 Jun 20.
Molecular target based combinational therapeutic approaches in thyroid cancer.
Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK.
J Transl Med. 2012 May 1;10:81. doi: 10.1186/1479-5876-10-81.
Inhibition of fatty acid synthase and Sp1 expression by 3,3'-diindolylmethane in human breast cancer cells.
Saati GE, Archer MC.
Nutr Cancer. 2011;63(5):790-4. doi: 10.1080/01635581.2011.570896. Epub 2011 Jun 22.
3,3'-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation.
Jin Y.
Mol Cell Biochem. 2011 Dec;358(1-2):345-54. doi: 10.1007/s11010-011-0985-0. Epub 2011 Jul 15.
3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells: retraction.
[No authors listed]
Anticancer Drugs. 2011 Mar;22(3):303. doi: 10.1097/CAD.0b013e328344b81f. No abstract available.
3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.
Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, Raz A, Rahman KM.
Int J Cancer. 2011 Oct 1;129(7):1781-91. doi: 10.1002/ijc.25839. Epub 2011 Mar 8.
3,3'-Diindolylmethane decreases VCAM-1 expression and alleviates experimental colitis via a BRCA1-dependent antioxidant pathway.
Huang Z, Zuo L, Zhang Z, Liu J, Chen J, Dong L, Zhang J.
Free Radic Biol Med. 2011 Jan 15;50(2):228-36. doi: 10.1016/j.freeradbiomed.2010.10.703. Epub 2010 Oct 26.
3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells.
Jin Y, Zou X, Feng X.
Anticancer Drugs. 2010 Oct;21(9):814-22. doi: 10.1097/CAD.0b013e32833e53ea. Retraction in: Anticancer Drugs. 2011 Mar;22(3):303.
Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments.
Bradlow HL, Zeligs MA.
In Vivo. 2010 Jul-Aug;24(4):387-91.
Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis.
Acharya A, Das I, Singh S, Saha T.
Recent Pat Food Nutr Agric. 2010 Jun;2(2):166-77. Review.
3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.
Rahimi M, Huang KL, Tang CK.
Cancer Lett. 2010 Sep 1;295(1):59-68. doi: 10.1016/j.canlet.2010.02.014. Epub 2010 Mar 17.
The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells.
Choi KH, Kim HK, Kim JH, Choi ES, Shin JA, Lee SO, Chintharlapalli S, Safe S, Abdelrahim M, Kong G, Choi HS, Jung JY, Cho HT, Cho NP, Cho SD.
Eur J Cancer Prev. 2010 Mar;19(2):153-9. doi: 10.1097/CEJ.0b013e328333d088.
Oral administration of 3,3'-diindolylmethane inhibits lung metastasis of 4T1 murine mammary carcinoma cells in BALB/c mice.
Kim EJ, Shin M, Park H, Hong JE, Shin HK, Kim J, Kwon DY, Park JH.
J Nutr. 2009 Dec;139(12):2373-9. doi: 10.3945/jn.109.111864. Epub 2009 Oct 28.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on